
At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
Unlock the market timeline & signal feed
49 signals in the last 90 days.
The order this company entered each market — oldest to newest
11 active postings
Scientist II, in vitro ADME screening
Sign up to see the full signal feed
How Charles River Laboratories's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
Charles River LaboratoriesYou | 10 | 0 | +350% | 44 | 30 |
Director Laboratory Operations
View postingVeszprém, Veszprém, Hungary · yesterday
Technician 2
View postingVeszprém, Veszprém, Hungary · yesterday
Lab Assistant
View postingVeszprém, Veszprém, Hungary · 4d ago
Norecopa: A Global 3Rs Research Database Resides in Norway
EndedBig Changes in European Pharma Legislation | Charles River
EndedFrom the Soil of Greece to the Forests of South Korea | Charles River
EndedThreeBillion uses AI to diagnose rare genetic diseases, supports precision genome analysis for ultra-rare YWHAG gene variant, and supplies AI-based genetic analysis solution GEBRA to Moroccan public health institutions.
The global biological buffers market is expected to grow from $741.69M in 2023 to $1,524.14M by 2033, at a CAGR of 7.47%, driven by increased R&D and biopharmaceutical production.
Locus Cell and Charles River signed an MoU to explore collaboration in CGT services, combining Locus Cell's manufacturing capabilities with Charles River's global expertise in biologics testing.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Charles River Laboratories's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.